10-102830536-G-GA
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1
The NM_000102.4(CYP17A1):c.*165_*166insT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.128 in 357,468 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0051 ( 2 hom., cov: 32)
Exomes 𝑓: 0.21 ( 0 hom. )
Consequence
CYP17A1
NM_000102.4 3_prime_UTR
NM_000102.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0520
Genes affected
CYP17A1 (HGNC:2593): (cytochrome P450 family 17 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. It has both 17alpha-hydroxylase and 17,20-lyase activities and is a key enzyme in the steroidogenic pathway that produces progestins, mineralocorticoids, glucocorticoids, androgens, and estrogens. Mutations in this gene are associated with isolated steroid-17 alpha-hydroxylase deficiency, 17-alpha-hydroxylase/17,20-lyase deficiency, pseudohermaphroditism, and adrenal hyperplasia. [provided by RefSeq, Jul 2008]
WBP1L (HGNC:23510): (WW domain binding protein 1 like) Predicted to enable ubiquitin protein ligase binding activity. Predicted to act upstream of or within CXCL12-activated CXCR4 signaling pathway; hemopoiesis; and positive regulation of protein ubiquitination. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.216 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP17A1 | NM_000102.4 | c.*165_*166insT | 3_prime_UTR_variant | 8/8 | ENST00000369887.4 | NP_000093.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP17A1 | ENST00000369887.4 | c.*165_*166insT | 3_prime_UTR_variant | 8/8 | 1 | NM_000102.4 | ENSP00000358903 | P3 | ||
CYP17A1 | ENST00000638190.1 | c.*165_*166insT | 3_prime_UTR_variant | 6/6 | 5 | ENSP00000492539 | ||||
CYP17A1 | ENST00000638971.1 | c.*165_*166insT | 3_prime_UTR_variant | 7/7 | 5 | ENSP00000492313 | ||||
WBP1L | ENST00000647664.1 | c.*418-189dup | intron_variant, NMD_transcript_variant | ENSP00000498131 |
Frequencies
GnomAD3 genomes AF: 0.00510 AC: 743AN: 145816Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
743
AN:
145816
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.213 AC: 45081AN: 211584Hom.: 0 Cov.: 3 AF XY: 0.212 AC XY: 23746AN XY: 111948
GnomAD4 exome
AF:
AC:
45081
AN:
211584
Hom.:
Cov.:
3
AF XY:
AC XY:
23746
AN XY:
111948
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00513 AC: 749AN: 145884Hom.: 2 Cov.: 32 AF XY: 0.00486 AC XY: 344AN XY: 70766
GnomAD4 genome
AF:
AC:
749
AN:
145884
Hom.:
Cov.:
32
AF XY:
AC XY:
344
AN XY:
70766
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Congenital adrenal hyperplasia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at